MicroRNA signatures in dilated cardiomyopathy: diagnostic performance and prognostic value from the European BestAgeing study
9 May 2026 (10:12 - 10:21)
Organised by: 
About the speaker
University Hospital Heidelberg, Heidelberg (Germany)
4 More presentations in this session
Mrs B. Del Hoyo Cuenda (Madrid, ES)
Serum transthyretin before and after starting tafamidis as outcome predictors in ATTR cardiomyopathy
Doctor V. Castiglione (Pisa, IT)
Doctor A. Aimo (Pisa, IT)
Ms J. Lee (Singapore, SG)
Access the full session
The Event
Heart Failure 2026
9 May 2026
10:12 CET
You may be interested in
Congress Session
Congress Session
